Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12570675 | Boronic acid compounds | 🖼🧊📄§ | 2026-03-10 | 2041-12-10 | 0 | 31 |
| 12570744 | Bispecific PD-1 and TIGIT binding proteins and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2044-02-14 | 0 | 31 |
| 12570622 | Therapeutic compounds | 🖼🧊📄§ | 2026-03-10 | 2042-11-29 | 0 | 31 |
| 12570614 | Phenyl amino pyrimidine compounds and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-04-20 | 0 | 31 |
| 12570628 | Salts of obicetrapib and processes for their manufacture and intermediates thereof | 🖼🧊📄§ | 2026-03-10 | 2045-04-14 | 0 | 31 |
| 12570958 | Single- and multi-chain chimeric antigen receptors | 🖼🧊📄§ | 2026-03-10 | 2038-12-19 | 0 | 31 |
| 12570975 | Composition for diagnosis or treatment of a condition associated with increased activity of EIF4E comprising an EIF4E inhibitor | 🖼🧊📄§ | 2026-03-10 | 2040-09-03 | 0 | 31 |
| 12570736 | Compositions | 🖼🧊📄§ | 2026-03-10 | 2040-06-19 | 0 | 31 |
| 12570735 | Compositions and methods for treating inflammasome related diseases or conditions | 🖼🧊📄§ | 2026-03-10 | 2039-07-03 | 0 | 31 |
| 12570727 | Antibodies specifically recognizing Pseudomonas Psl and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2041-08-04 | 0 | 31 |
| 12570605 | Indole compounds, and preparation methods, and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-09-02 | 0 | 31 |
| 12570612 | Substituted nitrogen heterocyclic compound and anesthetic effect thereof | 🖼🧊📄§ | 2026-03-10 | 2040-10-10 | 0 | 31 |
| 12570656 | Purine compounds for treating disorders | 🖼🧊📄§ | 2026-03-10 | 2041-03-09 | 0 | 31 |
| 12570687 | Triterpenoid compounds, pharmaceutical compositions thereof, and their use for treating a nuclear receptor subfamily 4 group a member 1-mediated disease | 🖼🧊📄§ | 2026-03-10 | 2040-09-14 | 0 | 31 |
| 12570689 | Purification of GLP-1 analogues | 🖼🧊📄§ | 2026-03-10 | 2040-02-05 | 0 | 31 |
| 12570694 | Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment | 🖼🧊📄§ | 2026-03-10 | 2042-09-14 | 0 | 31 |
| 12570709 | Self-assembling peptide amphiphiles displaying a transforming growth factor beta 1 (TGF-ß1) mimetic epitope | 🖼🧊📄§ | 2026-03-10 | 2042-07-28 | 0 | 31 |
| 12570759 | Polypeptides | 🖼🧊📄§ | 2026-03-10 | 2039-12-17 | 0 | 31 |
| 12569561 | Double stranded oligonucleotide construct comprising androgen receptor specific sequence, and composition for preventing hair loss and promoting hair growth comprising same | 🖼🧊📄§ | 2026-03-10 | 2039-11-18 | 0 | 31 |
| 12569481 | Methods of treatment for gastrointestinal motility disorders | 🖼🧊📄§ | 2026-03-10 | 2041-06-11 | 0 | 31 |
| 12569487 | Treatment of hidradenitis with jak inhibitors | 🖼🧊📄§ | 2026-03-10 | 2040-09-08 | 0 | 31 |
| 12569506 | Methods of treating osteonecrosis with LLP2A-bisphosphonate compounds | 🖼🧊📄§ | 2026-03-10 | 2040-08-18 | 0 | 31 |
| 12570973 | Compositions and methods for inhibiting intermediate filament tetramerization | 🖼🧊📄§ | 2026-03-10 | 2039-10-08 | 0 | 31 |
| 12571000 | Diaphragm-specific nucleic acid regulatory elements and methods and use thereof | 🖼🧊📄§ | 2026-03-10 | 2044-01-19 | 0 | 31 |
| 12571052 | Immunomodulatory RNA | 🖼🧊📄§ | 2026-03-10 | 2042-05-19 | 0 | 31 |
| 12570603 | FABP4/5 inhibitors, methods of use and methods of making | 🖼🧊📄§ | 2026-03-10 | 2042-09-14 | 0 | 31 |
| 12570608 | Compound derived from quinoline, use of a compound, composition and method for the treatment or prophylaxis of a condition caused by a blood parasite | 🖼🧊📄§ | 2026-03-10 | 2040-09-02 | 0 | 31 |
| 12570638 | Fused imidazole derivatives as AHR antagonists | 🖼🧊📄§ | 2026-03-10 | 2041-05-19 | 0 | 31 |
| 12570632 | Indole derivatives and uses thereof for treating a cancer | 🖼🧊📄§ | 2026-03-10 | 2041-07-06 | 0 | 31 |
| 12570652 | Pyrrolidine compound and use thereof | 🖼🧊📄§ | 2026-03-10 | 2041-05-14 | 0 | 31 |
| 12570651 | Quinazoline-2,4-dione derivatives as PARP inhibitors | 🖼🧊📄§ | 2026-03-10 | 2040-05-14 | 0 | 31 |
| 12570647 | Amino benzothiazole compounds for treatment of antibiotic resistant bacteria | 🖼🧊📄§ | 2026-03-10 | 2042-01-19 | 0 | 31 |
| 12570655 | Cysteine covalent modifiers of AKT1 and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2045-05-30 | 0 | 31 |
| 12570668 | Single molecule compounds providing multi-target inhibition of BTK and other proteins and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2039-07-22 | 0 | 31 |
| 12570673 | c-Myc protein inhibitor, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-07-03 | 0 | 31 |
| 12570685 | 2-methoxyestradiol derivatives and medical uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-10-14 | 0 | 31 |
| 12570715 | T cell receptors and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-07-29 | 0 | 31 |
| 12570712 | Cyclin A1 specific T cell receptors and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2039-02-12 | 0 | 31 |
| 12570714 | Siglec-based chimeric polypeptides and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-04-16 | 0 | 31 |
| 12570710 | Targeting LILRB4 with CAR-T or CAR-NK cells in the treatment of cancer | 🖼🧊📄§ | 2026-03-10 | 2038-11-06 | 0 | 31 |
| 12570719 | Chimeric antigen receptor comprising anti c-met antibody or antigen binding fragment thereof, and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-09-25 | 0 | 31 |
| 12570731 | Methods for treating cancer with an anti-apo B100 antibody | 🖼🧊📄§ | 2026-03-10 | 2040-11-12 | 0 | 31 |
| 12570730 | Chimeric antigen receptors for direct and indirect targeting of fibronectin-positive tumors | 🖼🧊📄§ | 2026-03-10 | 2040-07-17 | 0 | 31 |
| 12570738 | Multi-specific antibody with binding specificity for human IL-13 and IL-17 | 🖼🧊📄§ | 2026-03-10 | 2040-12-18 | 0 | 31 |
| 12570739 | Compositions and methods for improving health through modulating CALHM2 | 🖼🧊📄§ | 2026-03-10 | 2041-10-15 | 0 | 31 |
| 12570743 | BCMA-targeting engineered immune cell and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-05-06 | 0 | 31 |
| 12570754 | Regimens and methods of treating multiple sclerosis using ofatumumab | 🖼🧊📄§ | 2026-03-10 | 2043-06-08 | 0 | 31 |
| 12570755 | Anti-CD20 antibody and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2043-06-08 | 0 | 31 |
| 12570756 | Methods of use of anti-CD45 antibodies and conjugates thereof | 🖼🧊📄§ | 2026-03-10 | 2041-10-22 | 0 | 31 |
| 12569572 | Messenger RNA therapy for the treatment of Friedreich's ataxia | 🖼🧊📄§ | 2026-03-10 | 2040-09-10 | 0 | 31 |